日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pembrolizumab-induced myocarditis, myositis, and myasthenia gravis overlap syndrome (IM3OS) treated with Efgartigimod: case report

帕博利珠单抗诱发的心肌炎、肌炎和重症肌无力重叠综合征(IM3OS)经Efgartigimod治疗:病例报告

Cobelas-Cartagena, Stephanie S; Amigo-Otero, Emilio; García-Samblas, Victoria; Flores-Raposo, Jesus; Rodrigo-Herrero, Silvia; Bayo-Calero, Juan